Godfrey P. Oakley

Godfrey P. Oakley

Auto-generated profile, based on publicly available information

Godfrey P. Oakley

Center for Spina Bifida Prevention, Department of Epidemiology Rollins School of Public Health of Emory University Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2012 in Diabetes Care
Verified
Journal Article
Open access
LRLael Reinstatler
Lael Reinstatler
YQYan Ping Qi
Yan Ping Qi
RWRebecca S. Williamson
Rebecca S. Williamson
JGJoshua V. Garn
Joshua V. Garn
GOGodfrey P. Oakley
Godfrey P. Oakley
OBJECTIVE: To describe the prevalence of biochemical B12 deficiency in adults with type 2 diabetes taking metformin compared with those not taking metformin and those without diabetes, and explore whether this relationship is modified by vitamin B12 supplements. RESEARCH DESIGN AND METHODS: Analysis of data on U.S. adults ≥50 years of age with (n = 1,621) or without type 2 diabetes (n = 6,867) from the National Health and Nutrition Examination Survey (NHANES), 1999–2006. Type 2 diabetes was defined as clinical diagnosis after age 30 without initiation of insulin therapy within 1 year. Those with diabetes were classified according to their current metformin use. Biochemical B12 deficiency was defined as serum B12 concentrations ≤148 pmol/L and borderline deficiency was defined as >148 to ≤221 pmol/L. RESULTS: Biochemical B12 deficiency was present in 5.8% of those with diabetes using metformin compared with 2.4% of those not using metformin (P = 0.0026) and 3.3% of those without diabetes (P = 0.0002). Among those with diabetes, metformin use was associated with biochemical B12 deficiency (adjusted odds ratio 2.92; 95% CI 1.26–6.78). Consumption of any supplement containing B12 was not associated with a reduction in the prevalence of biochemical B12 deficiency among those with diabetes, whereas consumption of any supplement containing B12 was associated with a two-thirds reduction among those without diabetes. CONCLUSIONS: Metformin therapy is associated with a higher prevalence of biochemical B12 deficiency. The amount of B12 recommended by the Institute of Medicine (IOM) (2.4 μg/day) and the amount available in general multivitamins (6 μg) may not be enough to correct this deficiency among those with diabetes.

2 September 2013 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Closed access
PDF file
MYMonica E. Youngblood
Monica E. Youngblood
RWRebecca Williamson
Rebecca Williamson
KBKaren N. Bell
Karen N. Bell
QJQuentin Johnson
Quentin Johnson
VKVijaya Kancherla
Vijaya Kancherla
GOGodfrey P. Oakley
Godfrey P. Oakley

9 December 2008 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Closed access
PDF file
KBKaren N. Bell
Karen N. Bell
GOGodfrey P. Oakley
Godfrey P. Oakley


1 June 2014 in Seminars in Fetal and Neonatal Medicine
Verified
Journal Article
Closed access
VKVijaya Kancherla
Vijaya Kancherla
GOGodfrey P. Oakley
Godfrey P. Oakley
RBRobert L. Brent
Robert L. Brent

30 October 2020 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
VKVijaya Kancherla
Vijaya Kancherla
KWKaustubh Wagh
Kaustubh Wagh
HPHelena Pachón
Helena Pachón
GOGodfrey P. Oakley
Godfrey P. Oakley